PAPAIJV
LUMO

Paragon Associates & Paragon Associates II Joint Venture’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Paragon Associates & Paragon Associates II Joint Venture’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,000
Closed -$500K – 20
2021
Q2 		$500K Buy
+50,000
New +$500K 0.67% 15